IMDX

Insight Molecular Diagnostics Inc. - Common Stock (IMDX)

About Insight Molecular Diagnostics Inc. - Common Stock (IMDX)

Insight Molecular Diagnostics, Inc. is a diagnostics technology company, which engages in the development and commercialization of diagnostic tests for the detection of cancer, including molecular diagnostic services to pharmaceutical customers. Its products include DetermaRx and DetermaIO. The company was founded in September 2009 and is headquartered in Nashville, TN.

Details

Daily high

$4.18

Daily low

$3.99

Price at open

$4.10

52 Week High

$8.51

52 Week Low

$2.40

Market cap

135.2M

Dividend yield

Volume

183,525

Avg. volume

214,757

P/E ratio

-2.78

Insight Molecular Diagnostics Inc. - Common Stock News